Tourbillon Capital Partners’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Tourbillon Capital Partners’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,734	Closed	-$3.45M	–	89
2016 Q3	$3.45M	Hold	29,734	–	–	0.07%	68
2016 Q2	$2.36M	Sell	29,734 -15,625	-34%	-$1.35M	0.05%	59
2016 Q1	$3.45M	Sell	45,359 -53,623	-54%	-$3.41M	0.07%	60
2015 Q4	$8.87M	Buy	98,982 +780	+0.8%	+$74.9K	0.2%	61
2015 Q3	$11M	Buy	98,202 +16,952	+21%	+$1.95M	0.29%	69
2015 Q2	$8.27M	Buy	+81,250	New	+$8.41M	0.18%	84

Other funds holding PLXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Middleton & Co Boston, Massachusetts $877M AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tourbillon Capital Partners's PLXP Position: Q4 2016 in Review

Tourbillon Capital Partners sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2016, closing a stake of 29,734 shares — an estimated $3.45M sold.

Tourbillon Capital Partners first reported a position in PLXP in Q2 2015 and held it in 6 quarters. The position peaked at $11M in Q3 2015. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

Tourbillon Capital Partners reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Tourbillon Capital Partners sold 29,734 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $3.45M.
Tourbillon Capital Partners first reported a position in PLx Pharma Inc. Common Stock in Q2 2015 and held it in 6 quarters.
Tourbillon Capital Partners's PLx Pharma Inc. Common Stock position peaked at $11M in Q3 2015.
19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on Tourbillon Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.